FDA
Erlotinib Hydrochloride
The FDA lists this product in 38 strengths and forms.
Composition
- Active ingredients
- ERLOTINIB HYDROCHLORIDE EQ 150MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERLOTINIB HYDROCHLORIDE EQ 100MG BASE · TabletANDA091059-002 · Prescription
- ERLOTINIB HYDROCHLORIDE EQ 150MG BASE · TabletANDA091059-003 · Prescription
- ERLOTINIB HYDROCHLORIDE EQ 25MG BASE · TabletANDA091059-001 · Prescription
- ERLOTINIB HYDROCHLORIDE EQ 150MG BASE · TabletANDA211083-003 · Discontinued
- ERLOTINIB HYDROCHLORIDE EQ 25MG BASE · TabletANDA211083-001 · Discontinued
- ERLOTINIB HYDROCHLORIDE EQ 100MG BASE · TabletANDA211083-002 · Discontinued
- ERLOTINIB HYDROCHLORIDE EQ 150MG BASE · TabletANDA216342-003 · Discontinued
- ERLOTINIB HYDROCHLORIDE EQ 25MG BASE · TabletANDA216342-001 · Discontinued
- ERLOTINIB HYDROCHLORIDE EQ 100MG BASE · TabletANDA216342-002 · Discontinued
- ERLOTINIB HYDROCHLORIDE EQ 100MG BASE · TabletANDA208396-002 · Discontinued
- ERLOTINIB HYDROCHLORIDE EQ 150MG BASE · Tablet
At a glance
- Brand name
- Erlotinib Hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Natco Pharma LTD
- Status
- Discontinued
- FDA approval
- 5 Nov 2019
- Application
- ANDA208488-003